In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the use of gadolinium in MRI testing, specifically for patients with abnormal kidney function.

Previous Post
IMF’s Asian Myeloma Network Succeeds in Providing Access to Pomalidomide in Asia
Next Post
Crowdfunding for Myeloma Research: Is It a Good Idea?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.